PCI Pharma Services

PCI Pharma Services is a premier global CDMO offering comprehensive end-to-end solutions for drug development, clinical trial supply, and commercial manufacturing. With a network of facilities across North America, Europe, and Australia, the company supports a diverse portfolio of therapies, including oncology, gene and cell therapies, and complex injectables. Its strategic focus on integrated services, regulatory expertise, and advanced technologies positions it as a critical partner in bringing innovative medicines to market efficiently and reliably.

Integrated CDMO services platform encompassing drug development, clinical trial supply, commercial manufacturing (sterile injectables, oral solids), packaging, and global logistics for pharmaceuticals and biologics.

PCI competes with large public CDMOs like Catalent and Lonza, as well as numerous specialized firms. Its primary differentiation is a strong focus on integrated, end-to-end services from clinical development through commercial supply, particularly for complex injectables and biologics, positioning it as a strategic partner rather than just a vendor.